Review article: blood platelet number and function in chronic liver disease and cirrhosis
Open Access
- 5 March 2008
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 27 (11), 1017-1029
- https://doi.org/10.1111/j.1365-2036.2008.03674.x
Abstract
Background The liver plays a central role in coagulation and fibrinolysis but is also closely intertwined with the function and number of blood platelets. Aim To describe and integrate all literature concerning blood platelets and liver disease by performing a thorough literature research. Methods A thorough literature research on ‘blood platelets’ and ‘liver disease’ was performed. Results Thrombocytopenia is a marked feature of chronic liver disease and cirrhosis. Traditionally, this thrombocytopenia was attributed to passive platelet sequestration in the spleen. More recent insights suggest an increased platelet breakdown and to a lesser extent decreased platelet production plays a more important role. Besides the reduction in number, other studies suggest functional platelet defects. This platelet dysfunction is probably both intrinsic to the platelets and secondary to soluble plasma factors. It reflects not only a decrease in aggregability, but also an activation of the intrinsic inhibitory pathways. The net effect, finally, is a decreased platelet function in the various types of chronic liver diseases and cirrhosis. Finally, recent data suggest that platelets are not only affected by but can also contribute to the liver disease process, as for instance, in viral hepatitis and cholestatic liver disease. Conclusion Platelet research in liver disease is a growing area of investigation and could provide new pathophysiological insights.Keywords
This publication has 94 references indexed in Scilit:
- Platelet‐dependent accumulation of leukocytes in sinusoids mediates hepatocellular damage in bile duct ligation‐induced cholestasisBritish Journal of Pharmacology, 2008
- Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro modelJournal of Hepatology, 2003
- Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastographyJournal of Hepatology, 1997
- Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalitiesJournal of Hepatology, 1994
- Identification of the platelet glycoprotein IIb/IIIa complex as a target antigen in primary biliary cirrhosis-associated autoimmune thrombocytopeniaJournal of Autoimmunity, 1990
- Molecular mechanism underlying impaired platelet responsiveness in liver cirrhosisFEBS Letters, 1987
- Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia?Gut, 1985
- Kinetics and in vivo distribution of 111‐In‐labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopeniaScandinavian Journal of Haematology, 1985
- Effect of portacaval anastomosis on hypersplenismDigestive Diseases and Sciences, 1980
- Platelet function in chronic liver diseaseDigestive Diseases and Sciences, 1979